DLGAP1-AS1: A Potential Drug Target and Biomarker (G649446)

Target Name: DLGAP1-AS1

NCBI ID: G649446

DLGAP1-AS1

Other Name(s): DLGAP1 antisense RNA 1 | HsT914

DLGAP1-AS1: A Potential Drug Target and Biomarker

DLGAP1-AS1 (doublecortin-related GAP-activated protein 1-AS1) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the GAP-activated protein (GAP) family and is involved in a variety of cellular processes, including cell signaling, neurotransmission, and stress resistance. While the exact function of DLGAP1-AS1 is not yet fully understood, research has shown that it plays an important role in the regulation of cell proliferation and survival.

One of the key features of DLGAP1-AS1 is its ability to interact with other proteins, including the transcription factor, p53. This interaction between DLGAP1-AS1 and p53 suggests that the protein may be involved in the regulation of gene expression and that it may serve as a potential drug target. Additionally, the fact that DLGAP1-AS1 is highly conserved across various species and that it is expressed in many tissues and organs suggests that it may be a useful biomarker for certain diseases.

While the exact mechanism by which DLGAP1-AS1 interacts with p53 is not yet fully understood, it is thought to be involved in the regulation of p53 function. This is consistent with the idea that DLGAP1-AS1 may serve as a negative regulator of p53, as it appears to work to prevent the transcription factor from activating genes that are sensitive to its activity.

Another potential mechanism by which DLGAP1-AS1 may be involved in the regulation of gene expression is its role in the regulation of microRNA (miRNA) levels. miRNA is a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation by targeting mRNAs for degradation. While the exact mechanisms by which miRNA levels are regulated by DLGAP1-AS1 are not yet fully understood, it is thought to be involved in the regulation of miRNA levels by binding to a specific target on the miRNA precursor.

In addition to its potential role in the regulation of gene expression, DLGAP1-AS1 is also involved in the regulation of cellular stress responses. It has been shown that DLGAP1-AS1 is highly expressed in response to stress, including both physical and chemical stress, and that it plays an important role in the regulation of cellular stress responses. This suggests that DLGAP1-AS1 may be a potential drug target for diseases that are characterized by chronic stress, such as anxiety and depression.

The potential drug targeting of DLGAP1-AS1 is further supported by its expression in various tissues and organs, including the brain, where it has been shown to be highly expressed in response to various stress conditions, such as cold and heat. Additionally, the fact that DLGAP1-AS1 is highly conserved across various species and that it is expressed in many tissues and organs suggests that it may be a useful biomarker for certain diseases.

While the exact function of DLGAP1-AS1 is not yet fully understood, its potential as a drug target and biomarker suggests that it may be a valuable target for the development of new therapies for a variety of diseases. Further research is needed to fully understand the role of DLGAP1-AS1 in cellular processes and to determine its potential as a drug target.

Protein Name: DLGAP1 Antisense RNA 1

The "DLGAP1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DLGAP1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets